[CA 19-9 in the differential diagnosis of pancreatic lesions].
CA 19-9 is still used in the differential diagnosis of pancreatic lesions. As it has been shown to be elevated in many other non-pancreatic diseases--sometimes even extraordinarily--this marker should not be used to set the diagnosis of a pancreas carcinoma anymore. Especially if there is a concomitant cholestasis there is no diagnostic value to perform the measurement of CA 19-9. As the histological confirmation is the only way to get the exact diagnosis endoscopic ultrasound guided fine-needle aspiration biopsy should be considered in lesions of the pancreatic head.
Stintzing
S
S
Medizinische Klinik 1, Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen. sebastian.stintzing@uk-erlangen.de
Herold
C
C
Hahn
E G
EG
Boxberger
F
F
D000369:Aged, 80 and over; D014408:Biomarkers, Tumor / Q000097:blood*; D018395:CA-19-9 Antigen / Q000097:blood*; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D009363:Neoplasm Proteins / Q000097:blood*; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000175:diagnosis*
D014408:Biomarkers, Tumor; D018395:CA-19-9 Antigen; D009363:Neoplasm Proteins